Screening

Bottles of pills
#Cancer research #Drug development #Drug discovery #Oncology #Screening

Identify metabolic target pathways in cancer drug discovery

The regulation of cellular bioenergetics is recognised as a key driver of cancer cell proliferation. Identifying key pathways that modulate bioenergetic metabolism is a promising strategy for developing novel therapeutics for cancer treatment. Discover more in this new App Note from Agilent entitled ‘Rapid Bioenergetic Functional Screening of Anticancer Drug… Read More

#News

#Cancer research #Drug development #Drug discovery #Oncology #Screening

Learn about the rapid bioenergetic functional screening of anticancer drug candidates

The regulation of cellular bioenergetics is recognised as a key driver of cancer cell proliferation. Identifying key pathways that modulate bioenergetic metabolism is a promising strategy for developing novel therapeutics for cancer treatment. In this App Note you will learn: How the Agilent Seahorse XF Real Time ATP rate assay… Read More

#Resources

microRNA
#App note #Drug development #Drug discovery #mRNA #Purification technology #Screening

App Note: Achieve mRNA binding with DBC values over 6mg/mL

A new Application Note is now available to download from Sartorius BIA Separations. In this App Note, multi-parallel screening of binding conditions on CIM Oligo dT 96-well plates was performed to optimise the dynamic binding capacity (DBC) in the shortest time possible. What you will learn: How to effectively use Monolithic 96-well plates… Read More

#News

#Drug development #Drug discovery #mRNA #Purification technology #Screening

Discover how to achieve mRNA binding on Oligo dT with DBC values over 6mg/mL

In this Application Note, multi-parallel screening of binding conditions on CIM® Oligo dT 96-well plates was performed to optimise the dynamic binding capacity (DBC) in the shortest time possible. What you will learn: How to effectively use Monolithic 96-well plates when developing methods. They are unique on the market in combining the… Read More

#Resources

Biologics research
#Biologics #Drug development #Drug discovery #Guide #Monoclonal antibodies #Screening

Guide: Assessing thermal stability with nanoDSF

A new Guide ‘The biologics researcher’s mini-guide to screening candidates with nanoDSF’ is now available from NanoTemper. Among the most common critical quality attributes (CQAs) for early developability assessment is thermal stability. One particular tool for assessing thermal stability with high resolution is nano-differential scanning fluorimetry (nanoDSF). Read More

#News

#Biologics #Drug development #Drug discovery #Guide #Monoclonal antibodies #Screening

The biologics researcher’s mini-guide to screening candidates with nanoDSF

Among the most common critical quality attributes (CQAs) for early developability assessment is thermal stability. One particular tool for assessing thermal stability with high resolution is nano-differential scanning fluorimetry (nanoDSF). Read this mini-guide to learn: How nanoDSF uses your protein’s intrinsic fluorescence to determine its melting temperature, Tm and onset… Read More

#Intelligence #Resources

#3D modelling #Biochemistry #CRISPR #DNA #Drug discovery #Gene editing #Genomics #Mass spectrometry / NMR #Screening

Podcast: Mass spectrometry and CRISPR

This is the latest episode of the free DDW podcast, “Mass spectrometry and CRISPR are pillars of drug discovery”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How ASMS offers more than seeing what sticks” and “… Read More

#News

Kim and Bethan Nanion
#ApconiX #Cardiovascular disease #Drug discovery #Podcast #Screening

Podcast: The benefits of early ion channel screening

The latest sponsored DDW Sitting Down With podcast is now available. It features Dr Michael Morton, Director and Co-founder, ApconiX, and Dr Kimberly Rockley of ApconiX, who discuss the benefits of early ion channel screening. The podcast covers the hERG ion channel and its importance in cardiac safety screening… Read More

#News

Kim and Bethan Nanion
#ApconiX #Cardiovascular disease #Drug discovery #Podcast #Screening

The benefits of early ion channel screening

The latest sponsored DDW Sitting Down With podcast features Dr Michael Morton, Director and Co-founder, ApconiX, and Dr Kimberly Rockley of ApconiX who discuss the benefits of early ion channel screening. The podcast covers the hERG ion channel and its importance in cardiac safety screening in drug discovery. … Read More

#News

#Automation #CRISPR screening #Genomics #Imaging #Screening #SLAS2023

Image-based screening of pooled genetic libraries

Avtar Singh is a Senior Scientist in the Cell and Tissue Genomics Department at Genentech, where he develops new approaches for image-based screening and high-throughput biological discovery. DDW’s Megan Thomas spoke with Singh about SLAS2023, where he presented Image-based screening of pooled genetic libraries. MT: Why is SLAS2023 a prime… Read More

#Exclusive Content #Opinion

Scientists in laboratory
#Antibiotics #Antimicrobial resistance (AMR) #Antimicrobials #Collaboration #Cresset Discovery #Partnership #Screening

Virtual screening partners to find new antimicrobial drugs

Cresset Discovery and the University of Exeter have entered a collaboration to discovery novel antimicrobial drugs.  Cresset Discovery will use virtual screening to identify promising new candidates, building on research led by Dr Stefano Pagliara.  Virtual screening enables chemists to explore new chemical space, discover… Read More

#News

RNA
#Collaboration #Orbit Discovery #Partnership #Peptides #RNA #SanegeneBio #Screening

New partners hope to identify targeting peptides for RNAi drugs

Orbit Discovery and start-up SanegeneBio have entered into a Master Service Agreement to identify tissue-specific delivery of a wide range of RNA therapeutics.  The agreement covers activities ranging from hit ID to cell-based internalisation studies, with an option for Sanegene to further develop the hits resulting from… Read More

#Business & Investment #News

#Cell culture #Droplet-array sandwiching technology #Screening

Droplet-array sandwiching: Biochemical tools from droplets

Scientists showcase how the concentration of chemicals in droplets can be efficiently controlled by running experiments in the tiniest of cell cultures. These findings could be useful for more effective drug screening and cell-based analysis. Droplet-array sandwiching technology (DAST) lets one use droplets as tiny reaction chambers or cell culture… Read More

#Exclusive Content #News

#Assays #Drug discovery #Multiplexing #Screening

What you need to know about multiplexing in drug discovery

Download this guide from Abcam to learn more about: How multiplexing generates more insightful data The key principles, benefits and limitations of different multiplex assays How to select the most suitable multiplex assay for your screening program Click here to download… Read More

#News